PROCEPT BIOROBOTICS CORP
PRCTNASDAQ🏆 #2179 by market capEarnings Nov 2 · PostUS Equity
$21.44▼ $1.36 (−6.33%)
Live1h▼ 0.2%
24h▼ 6.3%
7d▲ 10.8%
14d▲ 19.9%
30d▲ 1.0%
1y▼ 44.4%
🏦Market Cap
$1.22B
Small Cap
📈Revenue Growth (YoY)
+22.7%
Healthy
📊Gross Margin
64.2%
High
💵FCF Margin
—
⚖️P/S Ratio
3.7x
Fair
Otter Score
57
Weak
📊
Analyst Ratings
Price
$21.44
Total
16
Raised
0
Lowered
5
Avg PT
$22.13
H / L
$29 / $19
| Institution | Action | Rating | Date |
|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-08-05 |
TD Cowen | Reiterated | Buy | 2026-08-05 |
William Blair | Downgraded | Outperform → Market Perform | 2026-08-05 |
Evercore ISI Group | Reiterated | Outperform | 2026-08-05 |
Truist Securities | Downgraded | Buy → Hold | 2026-07-06 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2026-06-11 |
Wells Fargo | Reiterated | Overweight | 2026-02-26 |
B of A Securities | Downgraded | Neutral → Underperform | 2026-02-26 |
Oppenheimer | Downgraded | Outperform → Perform | 2026-02-26 |
Morgan Stanley | Reiterated | Overweight | 2025-12-02 |
BTIG | Reiterated | Neutral | 2025-09-16 |
Keybanc | Reiterated | Overweight | 2023-05-01 |
Goldman Sachs | Reiterated | Neutral | 2022-11-04 |
SVB Leerink | Reiterated | Outperform | 2022-03-09 |
Cowen & Co. | Reiterated | Outperform | 2021-10-11 |
Guggenheim | Reiterated | Buy | 2021-10-11 |
One row per institution, most recent rating